Answers are grounded in this paper and cite their sources.
Ovarian immature teratoma (IT) is a rare neoplasm comprising ∼3% of ovarian cancers, occurring primarily in young females. In this case report a 17-year-old female was diagnosed with immature teratoma. The patient presented mass and dull aching pain in abdomen for duration of 6 months. On examination 20x15cm intraabdominal mass was noted which occupied whole of abdomen more on the right side, hard in consistency, mobile and lower border felt per vaginally in right fornix. CECT abdomen was done which showed a well-defined solid to cystic abdominopelvic mass measuring 20.3x 6.2x 15.8 cm probably arising from the right ovary. CECT chest was normal. Tumour markers S. Beta-hCG was 2 mIU/mL, S. LDH was 357 IU/mL, S. AFP was 1065 IU/ mL and S.CA-125 was 55.26 IU/mL. After multidisciplinary tumuor board discussion patient was planned for staging ovarian laparotomy (fertility preserving surgery). Intraoperatively ascites was present, mass was found to be arising from the right ovary measuring about 20 x15 cm free from all intraabdominal organs. Right fallopian tube and uterus was normal. Left ovary and fallopian tube was normal. Right pelvic, paracaval and precaval lymph nodes was enlarged. Liver, bilateral diaphragm and rest of the peritoneal cavity was normal. Patient underwent right ovarian mass excision with right salpingectomy, bilateral pelvic lymph node dissection, retroperitoneal lymph node dissection and supracolic omentectomy. On histopathological examination right ovary was reported as immature teratoma, grade 2 (high grade). Right fallopian tube, bilateral pelvic lymph nodes, supracolic omentum, retroperitoneal lymph nodes and ascitic fluid were free of tumour. On immunohistochemistry (IHC), right ovary tissue was positive for S-100 (highlighting immature neuroblast component) and SALL4 (germ cell tumour marker). From above findings, diagnosis of immature teratoma of right ovary was made FIGO stage IA (TNM stage pT1a pN0). Patient was advised adjuvant chemotherapy with Bleomycin, Etoposide and Cisplatin (BEP).
No takes yet. Share an insight, caveat, or question.
Saha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: